𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Targeting the immune system: novel therapeutic approaches in squamous cell carcinoma of the head and neck

✍ Scribed by Thomas K. Hoffmann; Henning Bier; Theresa L. Whiteside


Publisher
Springer-Verlag
Year
2004
Tongue
English
Weight
344 KB
Volume
53
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Targeted therapies in squamous cell carc
✍ Kathryn A. Gold; Ho-Young Lee; Edward S. Kim πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 170 KB πŸ‘ 3 views

## Abstract Head and neck cancer is a challenging disease that is expected to account for greater than 500,000 new cases worldwide in 2008. Toxicity has impeded advances in chemotherapy and radiation for head and neck cancer, and the prognosis for patients with recurrent and/or metastatic disease r

Elective neck irradiation in squamous-ce
✍ Mendenhall, William M. ;Million, Rodney R. ;Cassisi, Nicholas J. πŸ“‚ Article πŸ“… 1980 πŸ› Wiley (John Wiley & Sons) βš– 567 KB

## Abstract One hundred fifty‐nine patients with squamous‐cell carcinoma of the oral cavity, oropharynx, nasopharynx, hypopharynx, and supraglottic larynx, and with clinically negative neck (Stage NO) were reviewed to determine the value of elective neck irradiation (ENI). The primary cancer was co

Epidermal growth factor receptor targete
✍ Mark E. Sharafinski; Robert L. Ferris; Soldano Ferrone; Jennifer R. Grandis πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 382 KB πŸ‘ 2 views

## Abstract ## Background Cumulative evidence implicates the epidermal growth factor receptor (EGFR) as an important therapeutic target in head and neck squamous cell carcinoma (HNSCC). The basis for the lack of correlation between EGFR expression in the HNSCC tumor and clinical responses to EGFR